Clinical trials
Type 2 diabetes clinical trials
A condition where the body can’t use insulin properly, raising blood sugar. We’re tracking 1,079 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05759637Recruiting
Tests treatments for diabetes, weight, and high cortisol levels
This trial studies people who have type 2 diabetes and excess body weight, looking at how high cortisol (a stress hormone) may be involved. If you qualify, you may get a study treatment designed to improve diabetes and weight-related health by targeting cortisol-related pathways.
MilanAges 18–75 - NCT05766735Recruiting
Lifestyle program to lower sugar spikes after meals
This trial studies whether a structured lifestyle program can reduce “sugar spikes” after meals in people with early type 2 diabetes. It may help by combining coaching, tracking, and meal/activity changes to improve blood sugar control.
Aurora, ColoradoAges 30–80 - NCT05770687Recruiting
Testing diabetes heart medicine soon after a heart attack
This study looks at how starting an SGLT2 inhibitor (a diabetes medicine) around the time of a heart attack affects heart outcomes and heart muscle changes over time. It may help you and your care team understand whether this timing is beneficial after a PCI procedure.
SeoulAges 19 years+ - NCT05776420RecruitingPhase 3
Healthy food vouchers to improve blood sugar control
This trial tests whether giving people a healthy food voucher helps lower blood sugar levels in people who have prediabetes or type 2 diabetes. It also aims to support people who struggle with food or money by improving access to healthier foods.
TorontoAges 19 years+ - NCT05776563Recruiting
Testing whether brain sugar transport improves in type 2 diabetes
This study looks at whether the way the brain uses sugar (glucose) in people with type 2 diabetes can improve, and whether changes track with tighter diabetes treatment. You may get brain scans (MRI/MRS) and diabetes monitoring to see if there’s “reversibility” in the brain’s sugar transport.
New Haven, ConnecticutAges 18–60 - NCT05780905RecruitingPhase 4
Semaglutide study for brain blood flow in type 2 diabetes
This trial tests whether semaglutide changes blood flow in the brain and the brain’s “barrier” (how well the brain is protected) in people with type 2 diabetes. It may help researchers understand brain-related effects of diabetes treatment using scans and blood tests.
Seattle, WashingtonAges 40–65 - NCT05801614Recruiting
Tested diet to help control glucose in early type 2 diabetes
This study tests whether carbohydrate or calorie restriction can help normalize blood sugar levels in people with relatively early type 2 diabetes. It may help those whose diabetes control is not yet fully under control but who do not have major recent heart problems.
StockholmAges 24–70 - NCT05822609RecruitingPhase 2
Semaglutide for kidney disease in adults with type 1 diabetes
This Phase 2 study tests semaglutide (a diabetes and weight-related medicine) to see if it can slow or improve diabetic kidney disease in people with type 1 diabetes. You may be able to join if you have type 1 diabetes for at least 5 years and ongoing signs of kidney damage measured in urine tests.
Aurora, ColoradoAges 18 years+ - NCT05826054RecruitingPhase 1
Montbretin study in people with type 2 diabetes
This Phase 1 study tests montbretin to see how it works and is tolerated in adults. It includes people with type 2 diabetes (managed by diet only) and some healthy volunteers, to better understand safety and any early effects.
Vancouver, British ColumbiaAges 19–65 - NCT05844644RecruitingPhase 2
Golo plan for weight and blood sugar in prediabetes
This trial tests whether the Golo for Life plan (with a release supplement) can improve blood sugar and help with weight in adults who have prediabetes or type 2 diabetes. If you join, you’ll follow the program and attend clinic visits while your health, diet, and weight are tracked.
LaSalle, OntarioAges 18–75 - NCT05883072Recruiting
Using AI to support care for people with diabetes in Pakistan
This study tests whether AI-generated support can be helpful for adults living with diabetes. You may be asked to participate if you live in Pakistan and can legally consent.
Karachi, SindhAges 18–100 - NCT05884775Recruiting
Diabetes texting tool to track symptoms and improve care
This study tests a new phone/text-based system that asks people with type 2 diabetes about how they’re doing between visits. The goal is to help diabetes care and support better blood sugar control.
New York, New YorkAges 18 years+ - NCT05885828Recruiting
Precision nutrition study for type 2 diabetes in Hangzhou
This study tests a “precision” nutrition approach for people with type 2 diabetes. It aims to see whether personalized diet guidance is safe and helpful, compared with your current routine.
Hangzhou, ZhejiangAges 35–75 - NCT05887635Recruiting
RF treatment of the duodenum for type 2 diabetes control
This trial tests whether a procedure that uses heat energy (radiofrequency vapor ablation) applied in the first part of the small intestine (duodenum) can improve blood sugar control in adults with type 2 diabetes. It may help lower blood sugar when standard oral medicines are not keeping it in range.
SantiagoAges 18–65 - NCT05888909Recruiting
Tests better diagnosis and treatment planning for kidney disease in type 2 diabetes
This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.
BeijingAges 18 years+ - NCT05893927Recruiting
Diabetes app coaching for adults with poorly controlled type 2 diabetes
This trial tests whether a mobile website (on your phone) can help improve diabetes control in adults with type 2 diabetes that is not well controlled. If you qualify, you’ll likely use the app as part of diabetes education to see if it helps your health outcomes.
West Reading, PennsylvaniaAges 18 years+ - NCT05908812Recruiting
Testing how blood sugar control links to a hormone in type 2 diabetes
This study looks at whether better blood sugar control changes levels of a hormone called irisin in people with type 2 diabetes and obesity, including those with or without age-related muscle loss (sarcopenia). Your results may help researchers understand the body’s response to diabetes and could guide future treatment ideas.
BariAges 60 years+ - NCT05912647Recruiting
Program to improve diabetes control in adults with high A1c
This study tests a diabetes management program aimed at helping people with type 2 diabetes get better blood sugar control. It may help if your current diabetes medicines aren’t bringing your A1c down enough.
Madison, WisconsinAges 18–90 - NCT05958368Recruiting
Avocado study to improve blood sugar in type 2 diabetes
This study tests whether eating avocados can improve blood sugar control in adults with type 2 diabetes. You may have blood tests and will follow a specific eating plan while your diabetes care continues under your doctor.
Baton Rouge, LouisianaAges 18–65 - NCT05970237Recruiting
Dapagliflozin for type 2 diabetes with high blood pressure
This trial studies whether dapagliflozin (the medicine in Trudapa tabs) is safe and works in people who have both type 2 diabetes and high blood pressure. It may help control blood sugar and blood pressure, while researchers closely watch for side effects.
Incheon, Namdong-guAges 19 years+ - NCT06005987Recruiting
Using a mobile app to track diabetes in pregnancy
This study tests whether a mobile app helps people with diabetes during pregnancy track their blood sugar and health. The app is designed to make logging easier and may help you and your doctor manage your pregnancy better.
Augusta, GeorgiaAges 18–100 - NCT06028503Recruiting
Diabetes self-management help for rural adults
This study tests a program to help people with type 2 diabetes living in rural areas better manage their condition. It uses a smartphone app and coaching to improve blood sugar control.
Conroe, TexasAges 18 years+ - NCT06035874Recruiting
Bempedoic acid for fatty liver in type 2 diabetes
This trial tests if bempedoic acid, a cholesterol-lowering drug, can reduce liver fat in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help those who have stable blood sugar and are not on certain other medications.
Gurgaon, HaryanaAges 20 years+ - NCT06067139Recruiting
Sleep therapy to lower diabetes risk in prediabetes
This study tests if a sleep-focused therapy (cognitive behavioral therapy for insomnia, or CBT-I) can lower diabetes risk in people with prediabetes and insomnia. Participants will receive online therapy sessions and wear a monitor to track blood sugar and sleep.
Portland, OregonAges 22–79
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes?
- Yes. Clin2 currently lists 1,079 recruiting type 2 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.